Certified storage of characterised cell lines for reproducible therapy.
Harvesting and cryopreserving your cells (usually from cord blood or fat at birth/electively) for future medical use—the idea being you'll have a ready supply if you ever need regenerative therapy. It's marketed as preventive; the reality is uncertain: cell viability after decades of storage is unproven, regulatory pathways are evolving, and the bank may close or lose samples. If considering banking, verify the company's insurance, governance structure, and whether independent audits confirm their storage conditions. Many patients pay thousands upfront and never use the cells; banks rely on this model to stay afloat.
StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.
Get an honest assessment